The current stock price of SHPG is 179.2 null. In the past month the price increased by 4.49%. In the past year, price increased by 14.24%.
Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)
SHIRE PLC
BLOCK 2 MIESIAN PLAZA 50-58 BAGGOT STREET LOWER
Dublin L2 D02
CEO: Flemming Ornskov
Phone: 353-1609-6000
Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)
The current stock price of SHPG is 179.2 null. The price increased by 4.1% in the last trading session.
SHIRE PLC (SHPG) has a dividend yield of 0.19%. The yearly dividend amount is currently 0.34.
SHPG has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
SHPG stock is listed on the Nasdaq exchange.
The PE ratio for SHIRE PLC (SHPG) is 11.67. This is based on the reported non-GAAP earnings per share of 15.36 and the current share price of 179.2 null.
SHIRE PLC (SHPG) has a market capitalization of 54.71B null. This makes SHPG a Large Cap stock.
ChartMill assigns a technical rating of 7 / 10 to SHPG. When comparing the yearly performance of all stocks, SHPG is one of the better performing stocks in the market, outperforming 89.69% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to SHPG. While SHPG is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months SHPG reported a non-GAAP Earnings per Share(EPS) of 15.36. The EPS increased by 15.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 30.63% | ||
| ROA | 7.54% | ||
| ROE | 12.9% | ||
| Debt/Equity | 0.36 |